EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated Asporin expression in human atherosclerotic plaques promotes their stability and reduces the risk for cardiovascular events

Panagiotis Fountas iD, Chrysostomi Gialeli iD, Nicoline W Thorsen iD, Dianne Acoba iD, Jiangming Sun iD, Luke F Gamon iD, Annelie Shami iD, Mihaela Nitulescu, Ana Persson, Eva Bengtsson iD, Michael J Davies iD, Andreas Edsfeldt iD und 2 weitere

Cardiovascular Research · 2026

DOI: 10.1093/cvr/cvag015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2026. Verfasst von Panagiotis Fountas und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Translational Studies, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Vascular Calcification, Extracellular Matrix Proteins, Carotid Artery Diseases. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Physiographic Society in Lund, Lund University, Swedish Foundation for Strategic Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Vascular atherosclerotic calcification is a pathological process marked by the abnormal deposition of calcium minerals in the intima. Asporin (ASPN) is a small leucine-rich proteoglycan which interacts with collagen and calcium. Due to its role in matrix mineralization, we hypothesized that ASPN might act as a regulator of vascular calcification, thereby promoting atherosclerotic plaque stability. Methods and results ASPN protein, analysed by ELISA, was quantified in 176 carotid endarterectomy plaques (Carotid Plaque Imaging Project cohort, including 98 patients with cerebrovascular symptoms and 78 asymptomatic patients). Plaque composition was assessed by histological, biochemical, and immunological assays, along with bulk RNA sequencing, to investigate the role of ASPN in atherosclerosis. Patients donating plaques were followed up for post-operative cardiovascular events, median follow-up 6.58 years. The effect of ASPN on smooth muscle cell (SMC) differentiation and matrix mineralization was investigated in vitro using human vascular SMCs overexpressing ASPN. Increased ASPN protein levels were observed in plaques from asymptomatic patients compared with patients with cerebrovascular symptoms. ASPN protein levels were positively associated with markers of plaque stability and regulation of extracellular matrix remodelling while showing an inverse relationship with calcification. Patients with high intraplaque ASPN had a lower risk for future cardiovascular events. Mechanistically, ASPN overexpression in vascular SMCs reduced matrix mineralization in vitro, supporting its potential role in plaque stabilization.

Conclusion

ASPN is a regulator of vascular calcification in atherosclerosis, promoting a plaque phenotype that is less prone to rupture. Additionally, high ASPN levels are associated with fewer future cardiovascular events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plaque, AtheroscleroticVascular CalcificationExtracellular Matrix ProteinsCarotid Artery DiseasesMyocytes, Smooth MuscleMuscle, Smooth, VascularHumansFemaleMaleAgedMiddle AgedUp-RegulationCells, CulturedRupture, SpontaneousRisk FactorsEndarterectomy, CarotidTime FactorsCell Differentiation

Stichwörter der Autor:innen

AsporinCalcificationHuman atherosclerosisPlaque

Substanzen

Extracellular Matrix ProteinsASPN protein, human

Autor:innen und Institutionen

  • Cardiovascular Research Translational Studies, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
  • Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, Sweden.
  • Biofilms-Research Center for Biointerfaces, Malmö University, Malmö, Sweden.
  • Department of Cardiology, Skåne University Hospital, Malmö, Sweden.
  • Wallenberg Center for Molecular Medicine, Lund University, Malmö, Sweden.

ORCID-Profile: Panagiotis Fountas, Chrysostomi Gialeli, Nicoline W Thorsen, Dianne Acoba, Jiangming Sun, Luke F Gamon, Annelie Shami, Eva Bengtsson, Michael J Davies, Andreas Edsfeldt, Claudia Goettsch, Isabel Gonçalves

Förderung

  • Royal Physiographic Society in Lund
  • Lund University
  • Swedish Foundation for Strategic Research
  • Novo Nordisk Foundation
  • Knut and Alice Wallenberg Foundation

Zitieren

APA

Fountas, P., Gialeli, C., Thorsen, N. W., Acoba, D., Sun, J., Gamon, L. F., Shami, A., Nitulescu, M., Persson, A., Bengtsson, E., Davies, M. J., Edsfeldt, A., Goettsch, C., & Gonçalves, I. (2026). Elevated Asporin expression in human atherosclerotic plaques promotes their stability and reduces the risk for cardiovascular events. Cardiovascular Research. https://doi.org/10.1093/cvr/cvag015

Vancouver

Fountas P, Gialeli C, Thorsen NW, Acoba D, Sun J, Gamon LF, et al. Elevated Asporin expression in human atherosclerotic plaques promotes their stability and reduces the risk for cardiovascular events. Cardiovascular Research. 2026. doi:10.1093/cvr/cvag015

BibTeX
@article{Fountas2026,
  author = {Fountas, Panagiotis and Gialeli, Chrysostomi and Thorsen, Nicoline W and Acoba, Dianne and Sun, Jiangming and Gamon, Luke F and Shami, Annelie and Nitulescu, Mihaela and Persson, Ana and Bengtsson, Eva and Davies, Michael J and Edsfeldt, Andreas and Goettsch, Claudia and Gonçalves, Isabel},
  title = {Elevated Asporin expression in human atherosclerotic plaques promotes their stability and reduces the risk for cardiovascular events},
  journal = {Cardiovascular Research},
  year = {2026},
  doi = {10.1093/cvr/cvag015}
}
Kostenlos starten →